Literature DB >> 14567561

Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves' disease.

T Kalantari1, H Mostafavi, A M Pezeshki, S Farjadian, M Doroudchi, F Yeganeh, A Ghaderi.   

Abstract

Polymorphisms in ctla-4 gene have been shown to be associated with the Graves' disease (GD) susceptibility in different populations in the world. This study was undertaken to disclose the probable association of exon-1 polymorphism of ctla-4 with GD in Iranian patients. A49G polymorphism was investigated in 90 patients and 90 age/sex matched normal healthy controls, using PCR-SSCP and PCR-RFLP methods. Frequencies of AA, AG and GG genotypes among patients were found to be 21 (23.3%), 49 (54.5%) and 20 (22.2%) while these frequencies among healthy controls were 30 (33.3%), 53 (58.9%) and 7(7.8%), respectively. A significant increase of GG genotype and G allele was observed in patients (p = 0.012 and p = 0.025). In conclusion, consistent with the results of most other studies, the presence of a G allele in position 49 of ctla-4 exon-1 is associated with susceptibility to GD in Iranian population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567561     DOI: 10.1080/0891693032000114544

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  8 in total

1.  Exon-1 polymorphism of ctla-4 gene is not associated with systemic sclerosis in Iranian patients.

Authors:  A Rajaee; A Ebrahimi; A Fotouhi Ghiam; T Kalantari; A Ghaderi
Journal:  Rheumatol Int       Date:  2005-09-28       Impact factor: 2.631

2.  A Study on the Level of T(3), T(4), TSH and the Association of A/G Polymorphism with CTLA-4 Gene in Graves' Hyperthyroidism among South Indian Population.

Authors:  P Veeramuthumari; W Isabel; K Kannan
Journal:  Indian J Clin Biochem       Date:  2010-12-29

3.  Influence of cytotoxic T lymphocyte antigen 4 genetic variants on acute rejection in kidney transplant patients: precision medicine perspective.

Authors:  Andia Taleb; Mahdi Afshari; Mohammad Samzadeh; Negar Sarhangi; Mohsen Nafar; Mandana Hasanzad
Journal:  J Diabetes Metab Disord       Date:  2021-12-02

4.  CTLA-4 A49G gene polymorphism is not associated with vitiligo in South Indian population.

Authors:  Farha Deeba; Rabbani Syed; Jariya Quareen; M A Waheed; Kaiser Jamil; Hanmanth Rao
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

5.  Cytotoxic T lymphocyte antigen-4 promoter -658CT gene polymorphism is associated with ulcerative colitis in Chinese patients.

Authors:  Yan Luo; Bing Xia; Chun Li; Zhitao Chen; Liuqing Ge; Ting Jiang; Feng Zhou; Yan Zhao
Journal:  Int J Colorectal Dis       Date:  2008-12-16       Impact factor: 2.571

6.  Association between rs3087243 and rs231775 polymorphism within the cytotoxic T-lymphocyte antigen 4 gene and Graves' disease: a case/control study combined with meta-analyses.

Authors:  Yaqin Tu; Guorun Fan; Yu Dai; Tianshu Zeng; Fei Xiao; Lulu Chen; Wen Kong
Journal:  Oncotarget       Date:  2017-11-27

7.  Investigation of the Correlation between Graves' Ophthalmopathy and CTLA4 Gene Polymorphism.

Authors:  Ding-Ping Chen; Yen-Chang Chu; Ying-Hao Wen; Wei-Tzu Lin; Ai-Ling Hour; Wei-Ting Wang
Journal:  J Clin Med       Date:  2019-11-02       Impact factor: 4.241

8.  Association between the CTLA-4 +49A/G polymorphism and Graves' disease: A meta-analysis.

Authors:  Xiaoyu Si; Xiufeng Zhang; Wenru Tang; Ying Luo
Journal:  Exp Ther Med       Date:  2012-06-20       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.